Home › Compare › MTST vs XYLD

MTST vs XYLD: Dividend Comparison 2026

MTST yields 333333.33% · XYLD yields 11.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MTST wins by $8.099219044190773e+31M in total portfolio value
10 years
MTST
MTST
● Live price
333333.33%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.099219044190773e+31M
Annual income
$80,944,421,463,343,720,000,000,000,000,000,000,000.00
Full MTST calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
11.20%
Share price
$38.36
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.9K
Annual income
$3,351.03
Full XYLD calculator →

Portfolio growth — MTST vs XYLD

📍 MTST pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMTSTXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MTST + XYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MTST pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTST
Annual income on $10K today (after 15% tax)
$28,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$68,802,758,243,842,160,000,000,000,000,000,000,000.00/yr
XYLD
Annual income on $10K today (after 15% tax)
$952.37/yr
After 10yr DRIP, annual income (after tax)
$2,848.38/yr
At 15% tax rate, MTST beats the other by $68,802,758,243,842,160,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTST + XYLD for your $10,000?

MTST: 50%XYLD: 50%
100% XYLD50/50100% MTST
Portfolio after 10yr
$4.0496095220953863e+31M
Annual income
$40,472,210,731,671,860,000,000,000,000,000,000,000.00/yr
Blended yield
99.94%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTST buys
0
XYLD buys
0
No recent congressional trades found for MTST or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMTSTXYLD
Forward yield333333.33% ✓11.20%
Annual dividend / share$2.00$4.30 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$8.099219044190773e+31M$25.9K ✓
Annual income after 10y$80,944,421,463,343,720,000,000,000,000,000,000,000.00 ✓$3,351.03
Total dividends collected$8.098906375781879e+31M$20.2K ✓
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: MTST vs XYLD ($10,000, DRIP)

YearMTST PortfolioMTST Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$33,344,033$33,333,333.33$10,840$1,120.44+$33.33M → MTST
2$103,911,171,366$103,875,493,250.26$11,786$1,249.59+$103911.16M → MTST
3$302,644,656,190,810$302,533,471,237,448.00$12,854$1,397.78+$302644656.18M → MTST
4$823,817,797,451,856,400$823,493,967,669,732,100.00$14,063$1,568.33+$823817797451.84M → MTST
5$2,095,836,995,961,804,000,000$2,094,955,510,918,530,000,000.00$15,434$1,765.19+$2095836995961804.00M → MTST
6$4,983,251,920,823,462,000,000,000$4,981,009,375,237,783,000,000,000.00$16,995$1,993.14+$4983251920823461888.00M → MTST
7$11,073,835,968,753,321,000,000,000,000$11,068,503,889,198,040,000,000,000,000.00$18,777$2,257.95+$1.1073835968753322e+22M → MTST
8$22,999,277,308,531,336,000,000,000,000,000$22,987,428,304,044,770,000,000,000,000,000.00$20,818$2,566.58+$2.2999277308531335e+25M → MTST
9$44,643,905,199,991,210,000,000,000,000,000,000$44,619,295,973,271,085,000,000,000,000,000,000.00$23,163$2,927.50+$4.464390519999121e+28M → MTST
10$80,992,190,441,907,720,000,000,000,000,000,000,000$80,944,421,463,343,720,000,000,000,000,000,000,000.00$25,865$3,351.03+$8.099219044190773e+31M → MTST

MTST vs XYLD: Complete Analysis 2026

MTST — Stock

MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company's therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.

Full MTST Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this MTST vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTST vs SCHDMTST vs JEPIMTST vs OMTST vs KOMTST vs MAINMTST vs QYLDMTST vs JEPQMTST vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.